Milenkovic, J.; Stojanovic, D.; Velickovic, S.; Djordjevic, B.; Marjanovic, G.; Milojkovic, M.
Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors. Pathophysiology 2024, 31, 787-796.
https://doi.org/10.3390/pathophysiology31040053
AMA Style
Milenkovic J, Stojanovic D, Velickovic S, Djordjevic B, Marjanovic G, Milojkovic M.
Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors. Pathophysiology. 2024; 31(4):787-796.
https://doi.org/10.3390/pathophysiology31040053
Chicago/Turabian Style
Milenkovic, Jelena, Dijana Stojanovic, Sanja Velickovic, Branka Djordjevic, Goran Marjanovic, and Maja Milojkovic.
2024. "Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors" Pathophysiology 31, no. 4: 787-796.
https://doi.org/10.3390/pathophysiology31040053
APA Style
Milenkovic, J., Stojanovic, D., Velickovic, S., Djordjevic, B., Marjanovic, G., & Milojkovic, M.
(2024). Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors. Pathophysiology, 31(4), 787-796.
https://doi.org/10.3390/pathophysiology31040053
